Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma

Development of an Oncogenic Driver Alteration Associated Immune-Related Prognostic Model for Stage I-II Lung Adenocarcinoma

Lung adenocarcinoma (LUAD) needs to be stratified for its heterogeneity. Oncogenic driver alterations such as EGFR mutation, ALK translocation, ROS1 translocation, and BRAF mutation predict response to treatment for LUAD. Since oncogenic driver alterations may modulate immune response in tumor micro...

Full description

Bibliographic Details
Main Authors: Jian-Zhao Xu, Chen Gong, Zheng-Fu Xie, Hua Zhao
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Oncology
Subjects:
tumor microenvironment
immune-related prognostic model
lung adenocarcinoma
oncogenic driver alterations
The Cancer Genome Atlas
Gene Expression Omnibus
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2020.593022/full

Internet

https://www.frontiersin.org/articles/10.3389/fonc.2020.593022/full

Similar Items